U.S. Pharmaceutical Sales - Q2 2011
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q2 2011 by sales
- Sales Statistics Q2 2011
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 |
Lipitor
|
1,949,372 |
2.11% |
Stats |
2 |
Plavix
|
1,698,357 |
2.61% |
Stats |
3 |
Nexium AstraZeneca |
1,528,073 |
-1.65% |
Stats |
4 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,266,791 |
2.79% |
Stats |
5 ( 3) |
Singulair Merck |
1,160,959 |
11.74% |
Stats |
6 ( 1) |
Advair Diskus GlaxoSmithKline |
1,141,117 |
-2.39% |
Stats |
7 ( 1) |
Seroquel AstraZeneca |
1,129,442 |
-0.33% |
Stats |
8 ( 1) |
Crestor AstraZeneca |
1,072,498 |
2.32% |
Stats |
9 |
Actos Takeda Pharmaceutical Company Limited |
876,359 |
-13.56% |
Stats |
10 ( 2) |
Remicade Janssen Pharmaceuticals, Inc. |
865,903 |
7.61% |
Stats |
11 ( 2) |
Zyprexa
|
863,890 |
7.93% |
Stats |
12 ( 2) |
Cymbalta
|
861,431 |
5.03% |
Stats |
13 ( 2) |
Enbrel Amgen Inc. |
848,230 |
3.77% |
Stats |
14 |
Humira AbbVie Inc. |
844,296 |
6.32% |
Stats |
15 |
Neulasta Amgen Inc. |
818,068 |
4.04% |
Stats |
16 ( 4) |
Rituxan Genentech, Inc. |
734,378 |
7.26% |
Stats |
17 |
OxyContin Purdue Pharma LP |
726,420 |
2.82% |
Stats |
18 |
Lexapro Allergan plc |
720,870 |
3.15% |
Stats |
19 ( 3) |
Copaxone Teva Pharmaceuticals USA, Inc. |
720,747 |
0.29% |
Stats |
20 ( 1) |
Epogen Amgen Inc. |
720,376 |
3.32% |
Stats |
21 |
Avastin Genentech, Inc. |
649,802 |
-1.29% |
Stats |
22 |
Atripla Gilead Sciences, Inc. |
624,469 |
6.31% |
Stats |
23 |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
579,164 |
3.82% |
Stats |
24 ( 3) |
Januvia Merck |
509,786 |
8.81% |
Stats |
25 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
497,049 |
5.84% |
Stats |
26 ( 2) |
Lantus Sanofi |
488,609 |
-3.90% |
Stats |
27 ( 1) |
Truvada Gilead Sciences, Inc. |
481,921 |
8.66% |
Stats |
28 ( 1) |
Celebrex
|
443,024 |
1.25% |
Stats |
29 ( 1) |
Lyrica
|
439,764 |
0.72% |
Stats |
30 ( 3) |
Lucentis Genentech, Inc. |
424,611 |
0.95% |
Stats |
31 ( 3) |
Diovan HCT Novartis Pharmaceuticals Corporation |
423,209 |
4.51% |
Stats |
32 ( 4) |
Herceptin Genentech, Inc. |
398,348 |
3.62% |
Stats |
33 ( 4) |
Avonex Biogen |
379,639 |
2.45% |
Stats |
34 ( 5) |
Namenda Allergan plc |
369,408 |
5.72% |
Stats |
35 ( 3) |
OneTouch
|
368,206 |
2.37% |
Stats |
36 ( 5) |
Lantus Solostar Sanofi |
359,907 |
7.80% |
Stats |
37 ( 3) |
Gleevec Novartis Pharmaceuticals Corporation |
353,382 |
1.64% |
Stats |
38 ( 7) |
venlafaxine Generic |
339,124 |
-21.22% |
Stats |
39 ( 8) |
enoxaparin Generic |
336,755 |
8.08% |
Stats |
40 ( 2) |
Zetia Merck |
335,530 |
1.10% |
Stats |
41 ( 7) |
Procrit Janssen Pharmaceuticals, Inc. |
332,466 |
7.04% |
Stats |
42 ( 1) |
TriCor AbbVie Inc. |
322,121 |
-0.60% |
Stats |
43 ( 1) |
Geodon
|
322,015 |
-0.33% |
Stats |
44 ( 5) |
Vyvanse Takeda Pharmaceutical Company Limited |
305,102 |
-1.39% |
Stats |
45 ( 5) |
Niaspan AbbVie Inc. |
302,949 |
0.54% |
Stats |
46 ( 6) |
Lidoderm Endo Pharmaceuticals Inc. |
295,814 |
1.37% |
Stats |
47 ( 6) |
Suboxone
|
293,115 |
3.08% |
Stats |
48 ( 3) |
Aranesp Amgen Inc. |
291,873 |
-1.03% |
Stats |
49 ( 7) |
AndroGel AbbVie Inc. |
282,613 |
6.52% |
Stats |
50 ( 20) |
Provigil
|
275,098 |
17.28% |
Stats |
51 ( 4) |
Nasonex Merck |
270,076 |
0.96% |
Stats |
52 ( 27) |
Levaquin Janssen Pharmaceuticals, Inc. |
269,642 |
-42.70% |
Stats |
53 ( 8) |
Lovenox Sanofi |
265,753 |
-17.22% |
Stats |
54 |
Vytorin Merck |
265,600 |
-4.04% |
Stats |
55 ( ) |
Eloxatin Sanofi |
263,326 |
n/a |
Stats |
56 ( 24) |
Concerta Janssen Pharmaceuticals, Inc. |
261,309 |
-37.94% |
Stats |
57 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
256,985 |
-1.62% |
Stats |
58 ( 7) |
Lovaza GlaxoSmithKline |
254,718 |
3.98% |
Stats |
59 ( 2) |
Rebif EMD Serono, Inc. |
253,780 |
0.25% |
Stats |
60 ( 2) |
Symbicort AstraZeneca |
252,502 |
0.64% |
Stats |
61 ( 5) |
Novolog Novo Nordisk |
252,010 |
3.16% |
Stats |
62 ( 1) |
Adderall XR Takeda Pharmaceutical Company Limited |
251,839 |
1.34% |
Stats |
63 ( 4) |
Alimta Eli Lilly and Company |
251,739 |
3.76% |
Stats |
64 ( 5) |
Viagra
|
249,921 |
-2.00% |
Stats |
65 ( 3) |
Seroquel XR AstraZeneca |
249,529 |
2.86% |
Stats |
66 ( 9) |
amphetamine/dextroamphetamine Generic |
246,683 |
7.09% |
Stats |
67 ( 5) |
Humalog Eli Lilly and Company |
244,050 |
4.83% |
Stats |
68 ( 1) |
metoprolol Generic |
240,868 |
0.96% |
Stats |
69 ( 5) |
Flovent HFA GlaxoSmithKline |
237,395 |
-3.77% |
Stats |
70 ( 4) |
Neupogen Amgen Inc. |
236,294 |
2.51% |
Stats |
71 ( 5) |
Reyataz Bristol-Myers Squibb Company |
232,090 |
1.96% |
Stats |
72 ( 1) |
Aciphex Eisai Inc. |
223,768 |
-4.54% |
Stats |
73 ( 5) |
fentanyl Generic |
216,512 |
-0.62% |
Stats |
74 ( 1) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
215,302 |
-6.71% |
Stats |
75 ( 5) |
Levemir Novo Nordisk |
198,189 |
-0.11% |
Stats |
76 ( 3) |
Lunesta Sunovion Pharmaceuticals Inc. |
195,242 |
-2.53% |
Stats |
77 ( ) |
Varivax Merck |
194,653 |
n/a |
Stats |
78 ( 11) |
Janumet Merck |
193,079 |
8.93% |
Stats |
79 ( 33) |
donepezil Generic |
190,931 |
-39.00% |
Stats |
80 ( 1) |
Cialis Eli Lilly and Company |
190,377 |
0.51% |
Stats |
81 ( 16) |
bupropion Generic |
186,452 |
8.02% |
Stats |
82 ( ) |
docetaxel Generic |
185,282 |
n/a |
Stats |
83 ( ) |
methylphenidate Generic |
184,330 |
n/a |
Stats |
84 ( 16) |
Isentress Merck |
183,544 |
7.95% |
Stats |
85 ( 2) |
valacyclovir Generic |
183,317 |
-0.78% |
Stats |
86 ( 7) |
NovoLog FlexPen Novo Nordisk |
181,733 |
3.71% |
Stats |
87 ( 4) |
Evista
|
180,730 |
2.43% |
Stats |
88 ( 2) |
Restasis Allergan plc |
179,182 |
1.43% |
Stats |
89 ( 4) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
178,938 |
-2.17% |
Stats |
90 ( 2) |
Solodyn Medicis Pharmaceutical Corporation |
178,722 |
1.84% |
Stats |
91 ( 9) |
Zyvox Pfizer Inc. |
177,583 |
-4.59% |
Stats |
92 ( 2) |
Benicar Daiichi Sankyo |
172,226 |
-1.37% |
Stats |
93 ( 2) |
Erbitux Eli Lilly and Company |
172,185 |
-0.89% |
Stats |
94 ( ) |
Velcade Takeda Pharmaceutical Company Limited |
166,629 |
n/a |
Stats |
95 ( 18) |
budesonide Generic |
166,615 |
-24.47% |
Stats |
96 ( 8) |
Zometa Novartis Pharmaceuticals Corporation |
166,150 |
-6.47% |
Stats |
97 ( ) |
VESIcare Astellas Pharma US, Inc. |
161,704 |
n/a |
Stats |
98 ( ) |
acetaminophen/hydrocodone Generic |
160,975 |
n/a |
Stats |
99 ( ) |
Synthroid AbbVie Inc. |
160,142 |
n/a |
Stats |
100 ( 2) |
Detrol LA Viatris |
157,782 |
-7.49% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.